No idea, but would say it will cost less than the competitors , as Admedus being a one piece valve having 100 or so less stitches.
looking at the comparison test Pic posted above between Admedus and the competition, shows clearly there is no competition when it comes to design superiority and tissue.
TAVR presented at #JPM2020 by CEO, page-10
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.00 |
Change
-0.900(8.26%) |
Mkt cap ! $209.2M | |||
| Open | High | Low | Value | Volume |
| $10.50 | $10.79 | $9.30 | $1.271M | 128.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 128 | $9.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.00 | 540 | 1 |
View Market Depth
| Last trade - 15.45pm 06/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |